Chemoinformaics analysis of 7-Hydroxyhinokinin
| Molecular Weight | 386.356 | nRot | 4 |
| Heavy Atom Molecular Weight | 368.212 | nRig | 26 |
| Exact Molecular Weight | 386.1 | nRing | 5 |
| Solubility: LogS | -3.387 | nHRing | 3 |
| Solubility: LogP | 2.166 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 51.8183 |
| nHD | 2 | BPOL | 27.6057 |
| QED | 0.768 |
| Synth | 3.76 |
| Natural Product Likeliness | 1.323 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.907 |
| MDCK | 0.0000253 |
| BBB | 0.06 |
| PPB | 0.967601 |
| VDSS | 0.859 |
| FU | 0.0487921 |
| CYP1A2-inh | 0.935 |
| CYP1A2-sub | 0.158 |
| CYP2c19-inh | 0.952 |
| CYP2c19-sub | 0.175 |
| CYP2c9-inh | 0.809 |
| CYP2c9-sub | 0.863 |
| CYP2d6-inh | 0.978 |
| CYP2d6-sub | 0.678 |
| CYP3a4-inh | 0.951 |
| CYP3a4-sub | 0.376 |
| CL | 17.136 |
| T12 | 0.23 |
| hERG | 0.08 |
| Ames | 0.084 |
| ROA | 0.08 |
| SkinSen | 0.421 |
| Carcinogencity | 0.839 |
| EI | 0.264 |
| Respiratory | 0.097 |
| NR-Aromatase | 0.095 |
| Antiviral | Yes |
| Prediction | 0.601276 |